WEBSITECHANGES

Website Changes

---

01/07/2019

Biodegradable wafers releasing Temozolomide and Carmustine for the treatment of brain cancer.

---

12/26/2018

Do Corticosteroids Diminish Immune Checkpoint Blockade Efficacy?

---

12/24/2018

Tumour treating fields in a combinational therapeutic approach

---

12/24/2018

Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells

---

12/24/2018

Identification of a novel role of IL-13Ra2 in human Glioblastoma multiforme: interleukin-13 mediates signal transduction through AP-1 pathway

---

12/21/2018

FDA TO FACILITATE ACCESS TO UNAPPROVED DRUGS

---

12/20/2018

Penn Medicine Launching Telemedicine Platform for Brain Tumor Consults

---

12/19/2018

Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism.

---

12/15/2018

An early feasibility study of the Nativis Voyager® device in patients with recurrent glioblastoma: first cohort in US.

---

12/15/2018

Finding Hope in the Face of Brain Cancer

---

12/13/2018

Tumor treating fields increases membrane permeability in glioblastoma cells.

---

12/10/2018

Survivin Vaccine for Newly Diagnosed GBM

---

12/10/2018

Musella Foundation awards 2 more pediatric brain tumor research grants!

---

12/05/2018

Cancer therapy shows promise for some brain tumors

---

12/03/2018

Help Us Better Understand Glioblastoma Multiforme - Paid survey!

---

12/03/2018

Functional Biological Activity of Sorafenib as a Tumor-Treating Field Sensitizer for Glioblastoma Therapy.

---

11/22/2018

FDA Grants Fast Track Designation to ONC201 for the Treatment of Adult Recurrent H3 K27M-mutant High-Grade Glioma

---

11/22/2018

SNO 2018: Trials of Two Oncolytic Viruses for Recurrent Malignant Glioma Are Progressing

---

11/22/2018

The impact of traveling distance and hospital volume on post-surgical outcomes for patients with glioblastoma.

---

11/22/2018

Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target

---

11/22/2018

Giving Tuesday! Donate to Musella Foundation

---

11/20/2018

SNO Highlights

---

11/20/2018

Musella Foundation 2018 Highlights

---

11/11/2018

Mebendazole and radiation in combination increase survival through anticancer mechanisms in an intracranial rodent model of malignant meningioma.

---

11/10/2018

The role of erlotinib and the Optune device in a patient with an epidermal growth factor receptor viii amplified glioblastoma.

---